Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Point-of-Care Testing for COVID-19

Philip Seo, MD, MHS  |  Issue: February 2021  |  February 16, 2021

The Bubble

The National Basketball Association’s (NBA’s) 2020 season is the perfect example of what can be achieved with American ingenuity and a can-do attitude, when $8 billion—the revenue generated by an NBA season—is at stake.1 

On July 7, 2020, the 16 teams that made the NBA playoffs decamped to Walt Disney World in Orlando. The bubble comprised three Disney hotels and the ESPN Wide World of Sports Complex, where all practices and games were held. The idea was simple: If no one brought SARS-CoV-2 into the bubble, they could play out the rest of the season in a virus-free microcosm. 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

As with most simple ideas, the devil was in the details, which, in this case, were outlined in a 113-page booklet that delineated the plan: Two weeks prior to traveling to Orlando, all players were expected to quarantine at home and receive regular testing for COVID-19. After arriving at Orlando, all players remained in quarantine for an additional 48 hours and were tested for COVID-19 one more time before being allowed to leave isolation. All players, staff, coaches and reporters continued to be tested for COVID-19 daily. If anyone left the bubble, they would have to quarantine for an additional 10 days and have two negative COVID tests prior to being allowed to rejoin the bubble.2

The good news is that the bubble worked. On Oct. 11, 2020, the NBA season concluded without a single case of COVID-19 among the players, coaches or staff.3

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The bad news? The bubble was successful at preventing transmission of SARS-CoV-2 largely because of social distancing and isolation, in addition to frequent testing. 

Major League Baseball attempted a bubble-light approach, using a combi­nation of frequent testing and safety protocols that did not call for complete, physical isolation. The result? During the first week of play, 29 players tested positive for SARS-CoV-2. By Aug. 21, one-third of all teams had to postpone games due to infections with the coronavirus. 

The National Football League (NFL), similarly, refused to mandate the use of bubbles, and predictably, multiple teams were sidelined because of infections with SARS-CoV-2. The Baltimore Ravens, alone, had four unique strains of the coronavirus among their players, despite the NFL protocols.4 The problem is bad enough that the NFL scouting combine—the biggest event in the NFL calendar, in which draft prospects are evaluated in Indianapolis—will likely be replaced with Zoom interviews and telehealth examinations.5 So why bother testing at all?

Page: 1 2 3 4 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:COVID-19Testingvaccines

Related Articles

    Serological Antibody Tests in COVID-19: Test Reliability and Utility

    June 10, 2020

    Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…

    Corona Borealis Studio / shutterstock.com

    The Reliability & Utility of Serological Antibody Tests in COVID-19

    September 11, 2020

    Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…

    The Many Facets of COVID-19: Experts Address Basic & Clinical Research Concepts in the COVID-19 Era

    November 23, 2021

    New concepts in autoimmunity & immunology are being discovered daily in research being conducted to understand the SARS-CoV-2 virus and its implications for rheumatology & all fields of medicine. Here are some insights shared by experts during day 1 of the Basic and Clinical Research Conference.

    Research Helps Explain Idiosyncrasies of COVID-19

    November 23, 2021

    The Basic and Clinical Research Conference session on Rheumatology Complications of Emerging Viral Infections/SARS-CoV-2 presented findings from numerous studies that help explain some of the idiosyncrasies of COVID-19.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences